author-photo

Christoph Baumgärtel

Karolinska Institutet

23

Papers

325

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Austrian medicines authority positive towards biosimilar interchangeability

2017 Generics and Biosimilars Initiative journal
- Christoph Baumgärtel
Show All
- Source
- Cite
- Save
Citations (0)
Prevalence and determinants of unintended double medication of antihypertensive, lipid‐lowering, and hypoglycemic drugs in Austria: a nationwide cohort study

2016 Pharmacoepidemiology and Drug Safety
Show All
- Source
- Cite
- Save
Citations (7)
Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study.

2015 Applied Health Economics and Health Policy
Show All
- Source
- Cite
- Save
Citations (13)
Are generic immunosuppressants safe and effective

2015 BMJ
- Brian Godman
- Christoph Baumgärtel
Show All
- Source
- Cite
- Save
Citations (5)
Substantial savings with generics in Austria – and still room for more

2015 Generics and Biosimilars Initiative journal
- Christoph Baumgärtel
Show All
- Source
- Cite
- Save
Citations (0)
Generic pregabalin : current situation and implications for health authorities, generics and biosimilars manufacturers in the future

2015 Generics and Biosimilars Initiative journal
Show All
- Source
- Cite
- Save
Citations (8)
Generics authorization – groundbreaking regulatory approach to closer international cooperation on the rise – IGDRP

2015 Generics and Biosimilars Initiative journal
- Christoph Baumgärtel
- Katharina Gazda-Pleban
Show All
- Source
- Cite
- Save
Citations (0)
New product-specific bioequivalence guidance

2014 Generics and Biosimilars Initiative journal
- Christoph Baumgärtel
Show All
- Source
- Cite
- Save
Citations (0)
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.

2014 Frontiers in Pharmacology
Show All
- Source
- Cite
- Save
Citations (39)
New EU guidance for the evaluation of medicinal products with modified drug release will be finished by the middle of 2014

2014 Generics and Biosimilars Initiative journal
- Christoph Baumgärtel
- Jan Neuhauser
Show All
- Source
- Cite
- Save
Citations (0)